HEADER ENDOCYTOSIS 03-DEC-07 2RMY TITLE STRUCTURE OF THE N-TERMINAL BARPEPTIDE IN SDS MICELLES COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYC BOX-DEPENDENT-INTERACTING PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1-33; COMPND 5 SYNONYM: BRIDGING INTEGRATOR 1, AMPHIPHYSIN-LIKE PROTEIN, COMPND 6 AMPHIPHYSIN II, BOX-DEPENDENT MYC- INTERACTING PROTEIN 1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: K12; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: SUMO-FUSION KEYWDS BARPEPTIDE, MICELLE, NMR-STRUCTURE, ALTERNATIVE SPLICING, KEYWDS 2 ANTI-ONCOGENE, CELL CYCLE, COILED COIL, CYTOPLASM, KEYWDS 3 DEVELOPMENTAL PROTEIN, DIFFERENTIATION, ENDOCYTOSIS, HOST- KEYWDS 4 VIRUS INTERACTION, NUCLEUS, PHOSPHOPROTEIN, SH3 DOMAIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR C.LOEW,U.WEININGER,J.BALBACH REVDAT 3 24-FEB-09 2RMY 1 VERSN REVDAT 2 25-NOV-08 2RMY 1 JRNL REVDAT 1 14-OCT-08 2RMY 0 JRNL AUTH C.LOW,U.WEININGER,H.LEE,K.SCHWEIMER,I.NEUNDORF, JRNL AUTH 2 A.G.BECK-SICKINGER,R.W.PASTOR,J.BALBACH JRNL TITL STRUCTURE AND DYNAMICS OF HELIX-0 OF THE N-BAR JRNL TITL 2 DOMAIN IN LIPID MICELLES AND BILAYERS JRNL REF BIOPHYS.J. V. 95 4315 2008 JRNL REFN ISSN 0006-3495 JRNL PMID 18658220 JRNL DOI 10.1529/BIOPHYSJ.108.134155 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2.1 REMARK 3 AUTHORS : LINGE, O'DONOGHUE, NILGES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RMY COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-DEC-07. REMARK 100 THE RCSB ID CODE IS RCSB150048. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1MM [U-100% 15N] PROTEIN, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC, 3D 1H-15N REMARK 210 NOESY, 3D 1H-15N TOCSY, 3D REMARK 210 HNHA, 2D 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA 2.1 REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 30 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 2 -163.30 -162.13 REMARK 500 1 THR A 10 -62.06 -90.39 REMARK 500 2 ALA A 2 84.25 53.67 REMARK 500 2 GLU A 3 28.79 45.42 REMARK 500 2 MET A 4 -155.15 47.17 REMARK 500 2 SER A 6 -2.96 67.86 REMARK 500 2 THR A 10 -65.22 -96.55 REMARK 500 2 LEU A 33 -72.02 -80.68 REMARK 500 3 ALA A 2 -38.61 -162.77 REMARK 500 3 GLU A 3 -158.47 -74.80 REMARK 500 3 MET A 4 30.73 -169.21 REMARK 500 3 SER A 6 9.99 60.00 REMARK 500 3 THR A 10 -65.49 -102.50 REMARK 500 3 ALA A 11 0.40 -64.23 REMARK 500 3 LEU A 33 -71.94 -80.71 REMARK 500 4 ALA A 2 75.35 -164.18 REMARK 500 4 GLU A 3 -149.97 -160.16 REMARK 500 4 SER A 6 23.14 49.74 REMARK 500 4 LYS A 7 -70.48 -84.21 REMARK 500 5 ALA A 2 -59.40 -162.29 REMARK 500 5 MET A 4 38.15 -170.86 REMARK 500 5 LEU A 33 -81.90 -80.00 REMARK 500 6 ALA A 2 -161.36 -78.64 REMARK 500 6 MET A 4 25.52 49.21 REMARK 500 6 SER A 6 -0.67 -159.96 REMARK 500 6 LEU A 33 -71.80 -81.00 REMARK 500 7 MET A 4 49.96 38.25 REMARK 500 7 SER A 6 9.49 -159.18 REMARK 500 7 ALA A 11 -9.81 -57.05 REMARK 500 8 ALA A 2 83.98 -162.00 REMARK 500 8 GLU A 3 99.44 44.33 REMARK 500 9 GLU A 3 -82.73 56.21 REMARK 500 9 MET A 4 102.00 68.55 REMARK 500 9 THR A 10 -65.09 -101.52 REMARK 500 10 GLU A 3 -98.19 51.18 REMARK 500 10 MET A 4 77.07 39.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 C-TERMINAL TYROSIN 34 FOR CONCENTRATION DETERMINATION DBREF 2RMY A 1 33 UNP O00499 BIN1_HUMAN 1 33 SEQADV 2RMY TYR A 34 UNP O00499 SEE REMARK 999 SEQRES 1 A 34 MET ALA GLU MET GLY SER LYS GLY VAL THR ALA GLY LYS SEQRES 2 A 34 ILE ALA SER ASN VAL GLN LYS LYS LEU THR ARG ALA GLN SEQRES 3 A 34 GLU LYS VAL LEU GLN LYS LEU TYR HELIX 1 1 LYS A 7 TYR A 34 1 28 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 105 0 0 1 0 0 0 6 0 0 0 3 END